The diagnosis and management of CKD have been linked to a handful of well-established and routinely assessed biomarkers, including serum creatinine and more specifically the creatinine-derived and -calculated estimated glomerular filtration rate (eGFR), as well as urinary albumin excretion or the urine albumin creatinine ratio (UAE and UACR). This evidence concerns the gene ALB and chronic kidney disease.